tiprankstipranks
Iterum Therapeutics Plc (ITRM)
NASDAQ:ITRM
US Market

Iterum Therapeutics (ITRM) Financial Statements

706 Followers

Iterum Therapeutics Financial Overview

Iterum Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.641; its P/E ratio is -0.46; Iterum Therapeutics is scheduled to report earnings on August 9, 2024, and the estimated EPS forecast is $-0.45. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue----$ 0.00
Gross Profit-----
EBIT$ -7.05M$ -12.06M$ -9.77M$ -5.07M$ -29.04M
EBITDA$ -6.48M$ -11.03M$ -8.75M$ -4.22M$ -28.59M
Net Income Common Stockholders$ -7.10M$ -12.24M$ -9.67M$ -5.44M$ -29.11M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 18.21M$ 44.73M$ 51.82M$ 60.80M$ 64.36M
Total Assets$ 19.63M$ 51.02M$ 58.12M$ 66.83M$ 71.56M
Total Debt$ 12.20M$ 11.67M$ 10.88M$ 10.09M$ 30.21M
Net Debt$ -6.01M$ -33.07M$ -40.95M$ -50.71M$ -34.14M
Total Liabilities$ 25.77M$ 43.89M$ 39.16M$ 38.83M$ 39.01M
Stockholders Equity$ -6.15M$ 7.13M$ 18.96M$ 28.00M$ 32.55M
Cash Flow-
Free Cash Flow$ -13.08M$ -7.65M$ -9.59M$ -4.31M$ -4.55M
Operating Cash Flow$ -13.08M$ -7.63M$ -9.59M$ -4.26M$ -4.54M
Investing Cash Flow$ 7.21M$ 4.35M$ 5.11M$ 4.38M$ 15.85M
Financing Cash Flow$ 7.22M$ 200.00K$ 235.00K$ 433.00K$ 0.00
Currency in USD

Iterum Therapeutics Earnings and Revenue History

Iterum Therapeutics Debt to Assets

Iterum Therapeutics Cash Flow

Iterum Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis